ASCVD stands for atherosclerotic cardiovascular disease, defined as a nonfatal myocardial infarction (heart attack), coronary heart disease death, or stroke. It is useful i to estimate the risk of ASCVD within a 10-year period among patients who have never had one of these events in the past so that more active management such as cholesterol medication can be given to reduce the risk
A Calculator of Risk
The American Heart associations have developed a calculator to estimate the 10-year primary risk of ASCVD (atherosclerotic cardiovascular disease) among persons without pre-existing cardiovascular who are between 40 and 79 years of age. Patients are considered to be at “elevated” risk if predicted risk is ≥ 7.5%. that is that 7.5 of 100 people will get a cardiovascular event in the next 10 years
Current guidelines for the treatment of cholesterol with medication to reduce cardiovascular risk recommended that the following four groups of patients will benefit from statins which are the commonly used cholesterol medication e.g. lipitor
- Individuals with with known heart disease stroke etc
- Individuals with elevations of LDL ≥ 190 mg/dL ( bad cholesterol ) which would suggest it is genetic
- Individuals 40 to 75 years of age with diabetes and and LDL 70 to 189 mg/dL without clinical ASCVD
- Individuals without clinical ASCVD or diabetes who are 40 to 75 years of age with LDL 70 to 189 mg/dL and a 10-year ASCVD risk of 7.5% or higher
y
Lifetime ASCVD Risk
It is known that the risks of cardiovascular disease depends now how long a person has a high cholesterol. Thus a person having a high cholesterol at the age of 20 will be a much higher risk at the age of 40 year. This is the reason the Lifetime risk assessment in done in younger persons.
In individuals aged 20 to 59 years of age, a lifetime risk assessment is mentioned by guidelines A long-term risk assessment may be more accurate in younger individuals free from ASCVD (eg, 20 to 59 years old). This lifetime estimation was based on a paper published in 2006 that was developed by assigning a patient into one of five mutually exclusive sex-specific groups. In some cases, the 10-year ASCVD risk may be higher than lifetime risk due to differing mathematical approaches.
THIS IS A RISK CALCULAR
A KSHAMICAMD WEBSITE 